Cost-Effectiveness of an Exercise Programme That Provided Group or Individual Training to Reduce the Fall Risk in Healthy Community-Dwelling People Aged 65-80: A Secondary Data Analysis.
Otago Exercise Program
Tinetti
cost-effectiveness
direct healthcare costs
older adults
randomized controlled trial
risk fall
short physical performance battery
timed up and go
Journal
Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525
Informations de publication
Date de publication:
10 Jun 2021
10 Jun 2021
Historique:
received:
14
05
2021
revised:
31
05
2021
accepted:
08
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
Research has demonstrated that some exercise programs are effective for reducing fall rates in community-dwelling older people; however, the literature is limited in providing clear recommendations of individual or group training as a result of economic evaluation. The objective of this study was to assess the cost-effectiveness of the Otago Exercise Program (OEP) for reducing the fall risk in healthy, non-institutionalized older people. An economic evaluation of a multicenter, blinded, randomized, non-inferiority clinical trial was performed on 498 patients aged over 65 in primary care. Participants were randomly allocated to the treatment or control arms, and group or individual training. The program was delivered in primary healthcare settings and comprised five initial sessions, ongoing encouragement and support to exercise at home, and a reinforcement session after six months. Our hypothesis was that the patients who received the intervention would achieve better health outcomes and therefore need lower healthcare resources during the follow-up, thus, lower healthcare costs. The primary outcome was the incremental cost-effectiveness ratio, which used the timed up and go test results as an effective measure for preventing falls. The secondary outcomes included differently validated tools that assessed the fall risk. The cost per patient was USD 51.28 lower for the group than the individual sessions in the control group, and the fall risk was 10% lower when exercises had a group delivery. The OEP program delivered in a group manner was superior to the individual method. We observed slight differences in the incremental cost estimations when using different tools to assess the risk of fall, but all of them indicated the dominance of the intervention group. The OEP group sessions were more cost-effective than the individual sessions, and the fall risk was 10% lower.
Identifiants
pubmed: 34200873
pii: healthcare9060714
doi: 10.3390/healthcare9060714
pmc: PMC8230501
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Instituto de Salud Carlos III
ID : PI16/01520
Organisme : Instituto de Salud Carlos III
ID : PI16CIII/00031
Organisme : Instituto de Salud Carlos III
ID : PI16/00821
Organisme : Instituto de Salud Carlos III
ID : PI16/01316
Organisme : Instituto de Salud Carlos III
ID : PI16/01649
Organisme : Instituto de Salud Carlos III
ID : PI16/01042
Organisme : Instituto de Salud Carlos III
ID : PI16/01159
Organisme : Instituto de Salud Carlos III
ID : PI16/01312
Organisme : Regional Fund for Health Research (P. Vasco)
ID : 2016111005
Organisme : Regional Fund for Health Research (R. Murcia)
ID : FFIS17/AP/02/04
Références
Arch Phys Med Rehabil. 2019 Jan;100(1):1-8
pubmed: 30165053
J Adv Nurs. 2018 Jul;74(7):1700-1711
pubmed: 29633328
Med Clin North Am. 2015 Mar;99(2):281-93
pubmed: 25700584
PLoS One. 2011;6(11):e27899
pubmed: 22114723
Contemp Clin Trials. 2011 Nov;32(6):893-901
pubmed: 21782976
Pharmacoeconomics. 2009;27(6):519-28
pubmed: 19640014
Gerontology. 2008;54(5):272-80
pubmed: 18787321
Eur J Health Econ. 2010 Oct;11(5):513-20
pubmed: 20405159
Physiotherapy. 2017 Jun;103(2):180-185
pubmed: 27913064
J Cachexia Sarcopenia Muscle. 2019 Aug;10(4):721-733
pubmed: 31016897
Value Health. 2021 Mar;24(3):431-442
pubmed: 33641778
MMWR Morb Mortal Wkly Rep. 2016 Sep 23;65(37):993-998
pubmed: 27656914
Arch Osteoporos. 2018 Nov 9;13(1):122
pubmed: 30413893
Pharmacoeconomics. 2021 Jan;39(1):63-80
pubmed: 33015754
Disabil Rehabil. 2003 Jan 7;25(1):45-50
pubmed: 12554391
Pharmacoeconomics. 2011 Mar;29(3):189-98
pubmed: 21309615
J Am Geriatr Soc. 2008 Dec;56(12):2234-43
pubmed: 19093923
Trials. 2011 May 17;12:125
pubmed: 21586143
Health Econ. 1998 Jun;7(4):327-35
pubmed: 9683093
BMC Health Serv Res. 2018 Jul 20;18(1):574
pubmed: 30029649
J Safety Res. 2016 Sep;58:99-103
pubmed: 27620939
Aging Clin Exp Res. 2019 Oct;31(10):1435-1442
pubmed: 30515724
Am J Manag Care. 2016 Oct;22(10):638-644
pubmed: 28557514
Nurs Manag (Harrow). 2017 Feb 27;23(10):11
pubmed: 28240077
Physiotherapy. 2016 Sep;102(3):280-6
pubmed: 26395209
Clin Rehabil. 2019 Mar;33(3):524-534
pubmed: 30375234
Ann Intern Med. 2013 Mar 5;158(5 Pt 2):390-6
pubmed: 23460095
Cochrane Database Syst Rev. 2012 Sep 12;(9):CD007146
pubmed: 22972103
Clin Rehabil. 2004 Aug;18(5):498-508
pubmed: 15293484
Inj Prev. 2016 Dec;22(6):420-426
pubmed: 27222247
Ageing Res Rev. 2012 Jan;11(1):136-49
pubmed: 22101330
Arch Gerontol Geriatr. 2014 Mar-Apr;58(2):278-82
pubmed: 24275121
J Phys Act Health. 2018 Jun 1;15(6):397-402
pubmed: 29543112
Br J Sports Med. 2010 Feb;44(2):80-9
pubmed: 20154094
J Am Geriatr Soc. 2018 Apr;66(4):693-698
pubmed: 29512120
Gerontology. 2016;62(3):275-88
pubmed: 26645282
Br J Sports Med. 2017 Dec;51(24):1750-1758
pubmed: 27707740
Gerontology. 2018;64(5):503-512
pubmed: 29945150
Clin Interv Aging. 2018 May 11;13:903-912
pubmed: 29785097
BMC Geriatr. 2016 Apr 29;16:92
pubmed: 27129303
Osteoporos Int. 2017 Feb;28(2):585-595
pubmed: 27726000
JAMA Intern Med. 2019 Jan 1;179(1):28-36
pubmed: 30419096
N S W Public Health Bull. 2011 Jun;22(3-4):78-83
pubmed: 21632004
Inj Prev. 2017 Feb;23(1):22-26
pubmed: 27312961
Eur J Health Econ. 2016 May;17(4):391-402
pubmed: 25876834
Physiother Res Int. 2014 Jun;19(2):108-16
pubmed: 24339273
Osteoporos Int. 2010 Aug;21(8):1295-306
pubmed: 20195846
J Safety Res. 2015 Feb;52:65-70
pubmed: 25662884
Rev Med Chil. 2015 Jan;143(1):39-46
pubmed: 25860267
BMC Geriatr. 2017 Sep 1;17(1):199
pubmed: 28863774
Inj Prev. 2019 Aug;25(4):258-263
pubmed: 29363590
J Am Geriatr Soc. 2002 May;50(5):905-11
pubmed: 12028179
Geriatr Gerontol Int. 2010 Apr;10(2):191-8
pubmed: 20100287
Health Technol Assess. 2014 Aug;18(49):vii-xxvii, 1-105
pubmed: 25098959
Age Ageing. 2005 Nov;34(6):636-9
pubmed: 16267192
Health Econ. 2004 May;13(5):461-75
pubmed: 15127426
Health Econ. 2001 Dec;10(8):779-87
pubmed: 11747057
Phys Ther. 2000 Sep;80(9):896-903
pubmed: 10960937
Am J Public Health. 2012 Nov;102(11):2149-56
pubmed: 22994167
BMJ. 2013 Oct 29;347:f6234
pubmed: 24169944